Eli Lilly achieving significant gains in obesity results

Eli Lilly has achieved significant gains in the past quarter, leading to it becoming the most valuable pharmaceutical company in …

US FDA expands approval for Merck’s PREVYMIS (letermovir)

The US Food and Drug Administration (FDA) has granted approval for a new indication for Merck’s PREVYMIS (letermovir) to prevent …

EC grants marketing authorisation for Fennec’s Pedmarqsi

The European Commission (EC) has granted marketing authorisation for Fennec Pharmaceuticals’ Pedmarqsi (sodium thiosulfate) to reduce the risk of hearing …

ASCO 2023: Ellipses Pharma advances plans for RET inhibitor following encouraging results

Chicago, Illinois-based Ellipses Pharma has announced its intention to accelerate the global clinical development of its selective RET inhibitor EP0031/A400. Following …

Who’s posting what? Virtual Care related social media posts increased by 21% in the pharma industry in Q1 2023

The global pharma industry experienced a 21% rise in social media posts on virtual care in Q1 2023 compared with …